Literature DB >> 14402394

Limitations in the diagnostic value of serum leucine aminopeptidase.

E HOFFMAN, M M NACHLAS, S D GABY, S J ABRAMS, A M SELIGMAN.   

Abstract

Keywords:  GALLBLADDER/diseases; LIVER DISEASES/diagnosis; PANCREAS/diseases; PROTEASES/blood

Mesh：

Substances：

Year:  1960        PMID： 14402394     DOI： 10.1056/NEJM196009152631104

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  General medical aspects of malignant disease.

Authors:  J Q MATTHIAS
Journal:  Postgrad Med J       Date:  1961-06       Impact factor: 2.401

2.  [Leucine aminopeptidase (arylamidase) activity in the serum. Determination using leucine-p-nitroanilide as substrate].

Authors:  F Willig; I Greiner; H Stork; F H Schmidt
Journal:  Klin Wochenschr       Date:  1967-05-01

3.  Leucine amino peptidase a better indicator of carcinoma of liver, biliary tract and pancreas.

Authors:  M S Ghadge; A V Sirsat; M S Bhansali; L J Desouza; P Jagannath
Journal:  Indian J Clin Biochem       Date:  2001-01

4.  Leucine amino peptidase a better indicator of disseminated malignant disease.

Authors:  M S Ghadge
Journal:  Indian J Clin Biochem       Date:  2004-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.